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Abstract
Background: Human-beta defensins (HBD) belong to the family of acute phase peptides and hold a broad
antimicrobial spectrum that includes gram-positive and gram-negative bacteria. HBD are up-regulated after
severe injuries but the source of posttraumatic HBD expression has not been focused on before.
In the current study we analysed the role of liver tissue in expression of HBD after multiple trauma in human
and mice.
Methods: HBD-2 expression has been detected in plasma samples of 32 multiple trauma patients (ISS > 16) over
14 days after trauma by ELISA. To investigate major sources of HBD-2, its expression and regulation in plasma
samples, polymorphonuclear neutrophils (PMN) and human tissue samples of liver and skin were analysed by ELISA.
As liver samples of trauma patients are hard to obtain we tried to review findings in an established trauma model.
Plasma samples and liver samples of 56 male C57BL/6 N-mice with a thorax trauma and a femur fracture were
analysed by ELISA, real-time PCR and immunohistochemistry for murine beta defensin 4 (MBD-4) and compared
with the expression of control group without trauma.
The induction of HBD-2 expression in cultured hepatocytes (Hep G2) was analysed after incubation with IL-6,
supernatant of Staphylococcus aureus (SA) and Lipopolysaccharides (LPS). One possible signalling pathway was
tested by blocking toll-like receptor 2 (TLR2) in hepatocytes.
Results: Compared to healthy control group, plasma of multiple traumatized patients and mice showed significantly
higher defensin levels after trauma. Compared to skin cells, which are known for high beta defensin expression, liver
tissue showed less HBD-2 expression, but higher HBD-2 expression compared to PMN. Immunhistochemical staining
demonstrated upregulated MBD-4 in hepatocytes of traumatised mice. In HepG2 cells HBD-2 expression could be
increased by stimulation with IL-6 and SA. Neutralization of HepG2 cells with αTLR2 showed reduced HBD-2 expression
after stimulation with SA.
Conclusion: Plasma samples of multiple traumatized patients showed high expression of HBD-2, which may protect
the severely injured patient from overwhelming bacterial infection. Our data support the hypothesis that liver is one
possible source for HBD-2 in plasma while posttraumatic inflammatory response.
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Background
Multiple trauma is still the most frequent cause of death in
people under 40 years. Due to direct exposure of soft tissue
and bone to bacteria in case of open fracture and soft tissue
damage multiple traumatized patients are highly susceptible
to infectious complications [1, 2]. Furthermore severe
injuries lead to a depression of the immune system [3]
which favours infectious complications [4].
In previous studies we could demonstrate, that host-
defence peptides (HDP) are induced in plasma of mul-
tiple injured patients and provide extended antimicrobial
capacity [5].
Such peptides constitute an innate defence mechanism
that has been shown to be present in various kinds of
tissue like skin, lung, brain, stomach and bladder [6–8].
HBDs generally display potent activity against gram-
positive as well as gram-negative bacteria, virus and
fungi [9]. Additionally defensins and cathelicidins acti-
vate T- and B-cells, support wound healing and angio-
genesis and induce the attraction of neutrophils [10–13].
So far the sources of HDP in plasma of trauma patients
have not been identified yet. In contrast to that many
sources of inflammatory mediators and cytokines that
contribute to the posttraumatic inflammatory reaction
have been described several times [14]. Liver tissue has
been attributed with a special role in the release of such
mediators [15, 16]. Large amounts of IL-6 are locally
produced in the liver by Kupffer cells. Following major
trauma the IL-6 release correlates with injury severity
and mortality [17]. IL-6 is also known as a main inducer
of HBD-2 in vitro and can potentiate the microbial
killing activity of HBD-2 [18].
With regard to the potential of HDP in treatment of
multiple injured patients it is indispensable to discover
HDP producing cells and determine possible pathways
for its regulation.
The aim of this study was to detect possible sources
for HDP in plasma of multiple injured patients and to
find inducers and mechanisms of induction. As liver
constitutes an organ, which is vulnerable to trauma
damage and additionally plays a major role in the post-
traumatic inflammatory response, we focus on liver
tissue and compared this to skin as a well know produ-
cer of HBD-2. Due to the fact that human liver tissue
of multiple injured patients is hardly available for re-
search, we investigated the regulation of murine beta
defensin 4 (MBD-4) [19], which is comparable to the




Thirty two adult patients with multiple injuries (aged
18–65 years, male and female) were studied at the
Department of Trauma Surgery of the University
Medical Center of Schleswig-Holstein, Campus Kiel and
the Hannover Medical School, Germany. Data were ana-
lysed retrospectively. Inclusion criteria were an injury se-
verity score (ISS) of greater than 16 points without the
presence of severe traumatic brain injury (though abbre-
viated injury scales for head injury were included in the
ISS) and primary admission to the institutions. Exclusion
criteria were penetrating trauma and no direct admission
to either institution following the traumatic event. All
procedures were in concordance with the Revised
Version of the Declaration of Helsinki. The Ethics com-
mittee approval was obtained prior to the study for
trauma patient as well as for volunteer (control group)
sample analysis (AZ: D 415/08).
Control group
A group of 6 volunteers (3 women and 3 men), age 20
to 40 years, was randomly selected for determination of
the normal baseline values. Inclusion criteria were no
previous diseases, no medication or trauma and no pre-
vious operations.
Collection of blood
Venous EDTA-blood (9 ml Monovette, Sarstedt, Germany)
was collected daily at 7 a.m. from traumatized patients over
a 14-day period. The first sample was drawn directly after
admission to the hospital. Within 30 min the blood was
centrifuged for 10 min at 2000 g at room temperature. The
supernatant plasma was stored at −80 °C.
Recruitment of tissues
Epidermis was collected from 5 patients undergoing
osteosynthesis after fracture. After skin incision a 50 ×
2 mm piece of epidermis was cut for further examina-
tions. Liver tissue was harvested from 5 patients under-
going liver resection. 10 mg of macroscopic healthy
tissue was cut for further examination. All operations
were performed at the Departments for Trauma Sur-
gery and Visceral Surgery at the University Medical
Centre of Schleswig-Holstein, Kiel Campus. The local
ethics committee approval was obtained for the study
(AZ: D412/08).
Isolation of PMN with polymorph-prep©
Venous blood samples of 9 mL were taken from 5
healthy volunteers by the use of EDTA Monovettes.
PMN were isolated from whole blood using Polymorph-
Prep© (Axis-Shield, Norway) according to the manufac-
turer’s instructions. 5 mL of blood was carefully layered
on 5 mL of Polymorph-Prep©. After centrifuging at
500 × g for 30 min at room temperature mononuclear
cells and polymorphonuclear cells were separated and
resuspended in 0.45% NaCl.
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Cultivation and stimulation of immortalized liver cells
The experiments were performed with immortalized
liver cells, HepG2 (Cell Lines Service, Germany). These
cells represent histological and biological characteristics
of differentiated parenchymal liver cells [20].
Cells were cultivated as described in distributer’s in-
structions. For cultivation 800,000 cells were filled into a
25 cm2 cell culture bottle with 2 mL of cell medium. Cells
were stimulated with 50 ng/mL IL-6 (Tebu, Offenbach,
Germany) and supernatant of SA (1:100, assembled as de-
scribed by Gläser et al. [21]).
For neutralisation experiments, 400,000 cells were
cultivated, incubated with 10 μ g/mL TLR2 antibody
(eBioscience, San Diego, USA) for 1 h and stimulated
afterwards with SA (1:100). Incubation was performed at
37 °C in ambient humidity with 5% CO2 in an incubator.
All experiments were accomplished three times.
HBD-2 ELISA
Ninety six-well immunoplates (MaxiSorp, Nunc, Ros-
kilde, Denmark) were coated at 4 °C for 24 h with
100 μl of capture antibody. The antibodies were di-
luted in 0.05 M carbonate buffer, pH 9.6. Afterwards
the wells were blocked with 200 μl of 1% bovine
serum albumin in PBS for 60 min at room
temperature. After three times washing with 250 μl
of PBS + 0.05% Tween 20, 100 μl per well of sample
was incubated for 60 min at room temperature.
Plates were washed three times with PBS + 0.05%
Tween 20 and wells were incubated for 30 min at
room temperature with 100 μl of biotinylated
antibody diluted in 10 ml 0.1% BSA + PBS. Plates
were again washed three times with PBS + 0.1%
Tween 20 and filled with 100 μl/well of Streptavidin-
HRP (R&D Systems, Minneapolis, USA) diluted
1:200 in PBS + 0.05% Tween 20. The plates were
incubated for 30 min at room temperature, washed
three times as described above and incubated with
100 μl 3.3′,5.5′-Tetramethylbenzidine (Sigma-Al-
drich, St. Louis, USA) as the development agent for
5–10 min at room temperature in the dark. Absorb-
ance was measured at 450 nm with a multichannel
photometer (Sunrise; Tecan, Crailsheim, Germany).
For the ELISA experiments three wells of each sam-
ple were analysed.
For HDB-2 ELISA goat anti-HBD-2 antibody (Acris,
Hiddenhausen, Germany; PP1125P2) and biotinylated
goat anti-HBD-2 antibody (Acris, Hiddenhausen,
Germany; PP1125B2) were used in the concentration
0.5 and 0.25 μg/ml. Human recombinant HBD-2 was
(Acris, Hiddenhausen, Germany) served as the stand-
ard with the following concentrations: 0, 0.05, 0.1, 0.2,
0.39, 0.78, 1.56, 3.13, 6.25 ng/ml. Experiment were ac-
complished three times.
Immunohistochemistry
After fixation of human liver samples in 4% paraformal-
dehyde, the tissue was embedded in paraffin, sectioned
and dewaxed. Endogenous peroxidases in tissue sections
were blocked with 3% H2O2, and tissue sections were
subsequently incubated with normal serum (1:5 in Tris
buffered saline (TBS)) from the species in which the pri-
mary antibody was raised. Immunohistochemical stain-
ing was performed on 6 μm paraffin sections, using
polyclonal primary antibody against HBD-2 (Goat anti
Human Defensin beta 2, diluted 1:200, Acris). Incuba-
tion with primary antibody was performed at 4 °C for
12 h. Incubation with second antibody against HBD-2
(Polyclonal Antibody to Goat IgG, diluted 1:300, Acris)
was performed for 45 min and incubation with
streptavidin-peroxidase for 30 min. Afterwards washing
for 5 min was conducted three times. Samples were in-
cubated with DAB (6 mg of 3,3′-Diaminobenzidine tet-
rahydrochloride in 10 ml distilled water with 2 drops of
3% H2O2) as chromogen. After washing three times with
TBS for 5 min cell nuclei were counterstained with
Mayers-Haemalaun for 15 s followed by rinsing of sam-
ples for 5 min in distilled water. Samples were dehy-
drated with different concentrations of alcohol (50, 75,
90 and 95%) and after 5 min covered in Xylol with DPX.
Negative control was carried out while dispensing with
primary antibody.
Animal care
Ethical approval has obtained from Ethics Committee of
the MHH (Medizinische Hochschule Hannover) (AZ: V
312–72241.121-9 (25-2/11)). The study was performed
at the experimental trauma surgery laboratory of the
MHH. Experiments were conducted in an operating
room at the animal research facility. 56 male C57BL/
6 N-mice (Charles River, Germany) weighing 22 ± 3 g
were used for the study. 20 mice were used in prelimin-
ary experiments to determine the weight needed for in-
duction of chest trauma.
All mice were handled at room temperature for 14 days
before treatment and all mice were at the same age of
12 weeks. Throughout the study period, pelleted mouse
chow and water were available ad libitum. The lighting was
maintained on a 12-h light-dark cycle. Analgesic treatment
was administered to all animals (200 mg/kg metamizole so-
dium (Novalgin®, Hoechst, Unterschleißheim, Germany))
throughout the study. All surgical procedures were per-
formed under deep anesthesia with isoflurane (Baxter
AG, Volketswil, Germany) and local application of
xylazine (16 mg/kg) (Rompun®, Bayer, Leverkusen,
Germany). The mice were warmed to 36 °C using in-
frared heat lamps after the surgical procedures were
complete. Wound closure was performed before re-
covery from the anaesthesia.
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Group distribution and experimental procedures
Two different groups (n = 8) were included in the experi-
mental design: a) mice with a femur fracture and chest
trauma and b) mice with an intramedullary pin but with-
out chest trauma or femur fracture (control group). The
experimental design of the multiple trauma model is
based on a two-hit model. The first hit consisted of a
closed femur fracture on the right side with the femur
stabilized with a cannula before the fracture was per-
formed. The method used for the femur fracture model
was first described by Bonnarens (35). After primary
wound closure, standardized femur fracture was induced
using a blunt guillotine device weighing 500 g (0.784 J).
This resulted in a femoral fracture combined with soft
tissue injury. Chest trauma immediately followed femur
fracture as the second hit. The chest trauma model was
previously described for rats (36; 37). Trauma was in-
duced in anesthetized mice by dropping a hollow
aluminum cylindrical weight (300 g) through a vertical
stainless steel tube onto a Lexon platform resting on the
chest. The impact energy E (1.617 J) of the falling weight
was calculated using the equation E =m x g x h where
m =mass of aluminium weight (in kilograms), g = gravi-
tational acceleration (9.8 ms−2) and h = height of weight
above the Lexon platform (in meters). Calculations as-
sumed that all the potential energy of the weight was
transferred to the animal, neglecting frictional dissipa-
tion. The platform was suspended on Teflon guides to
minimize friction and facilitate energy transfer to the
anesthetized animal. The shield was reproducibly placed
entirely over the chest without intrusion onto the abdo-
men. Animals were sacrificed immediately after trauma,
after 6, 12, 24 h, 3 and 7 days and samples for histologic
examination were obtain afterwards.
Protein analysis of MBD-4
Blood samples obtained by heart puncture of mice were
centrifuged for five minutes. The supernatant was re-
moved and stored at −20 °C until processed. Concentra-
tions of MBD-4 in plasma samples were analysed by
Luminex assay according to standard protocols using
LiquiChip200 (Qiagen). A MBD-4 Elisa kit (ABIN415726,
antibodies online GmbH) was used for protein detection.
Every experiment was accomplished three times.
Immunhistology/Liver tissue of mice
Six Liver tissue samples of mice were embedded in paraf-
fin. Sections (5 μm) were cut out of the central portion of
the liver with a sliding microtome (HM 430; Microm
International). They were placed onto Superfrost Plus
microscope slides (Thermo Scientific) and left overnight
at 60 °C. Sections were routinely stained with hematoxylin
and eosin (H&E). Safranin O staining was carried out for
6 min, using a 0.1% aqueous solution at pH 3.0.
Real-time PCR
For real-time polymerase chain reaction (PCR), RNA
was isolated from mice liver tissue with the RNeasy-
Total RNA Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions. Total RNA (1,000 ng)
was used for reverse transcription and subsequent
Real-time PCR with gene-specific primers. Real-time
PCR was performed as described by Varoga et al.
[22]. The gene of interest was detected using TaqMan
probes: Mm00731768_m1 (Applied Biosystems, Foster
City, CA, USA).
Statistical analysis
Data is expressed as the mean ± SD of tested samples.
Statistical significance was evaluated using one-way
ANOVA with Bonferroni correction. Statistical signifi-
cance was assumed where probability values of less than
0.05 were obtained. Spearman’s linear regression analysis
was performed to evaluate correlation of protein plasma
concentrations.
Results
HBD-2 concentration in plasma samples of multiple
trauma patients
First we analysed plasma of multiple injured patients
and as a control plasma of healthy donors for HBD-2
retrospectively. On the day of trauma protein levels in-
creased 6 times compared to the healthy control group
(0.65 ng/ml ± 0.31) to a maximum concentration of
4.2 ng/ml ± 1.7 (Fig. 1a). On day five HBD-2 expression
decreased compared to day of trauma but was still sig-
nificantly higher than the control group. Subsequent
levels decreased, but did not reached levels of healthy
donors on day 14.
MBD-4 concentration in plasma samples of mice after
multiple trauma
Host defence peptides in plasma of multiple traumatised
mice were evaluated directly after trauma until day 7.
MBD-4 levels increased significantly to 15.18 ± 2.2 ng/ml
on day of trauma compared to control group (3.79 ±
0.5 ng/ml; Fig. 1b). MBD-4 levels decreased afterwards, but
did not reach the concentrations of control until day 7.
HBD-2 concentration in samples of lysed liver tissue, skin
and PMN
To evaluate possible sources of HBD-2 in human plasma
we analysed liver and PMN, whether they contained
comparable protein concentrations as skin, a well-
known producer of HBD-2 (Fig. 2). As expected skin
samples contained the highest concentration of HBD-2
(7.12 ng/mg wet weight ± 0.5). Liver tissue lysate showed
less concentration of HBD-2 compared to skin (5.55 ng/
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mg wet weight ± 0.5), but higher concentration com-
pared to PMN (0.3 ng/mg wet weight ± 0.5).
Immunohistochemestry of host defence peptides in liver
tissue of humans and multiple trauma mice
Immunohistochemistry was performed in liver speci-
mens of non-trauma patients to confirm the detection of
HBD-2 (Fig. 3a + b). Human liver samples showed strong
positive staining for HBD-2. Mice liver of animals with
multiple trauma revealed positive MBD-4 staining,
whereas control liver showed no reactivity (Fig. 3c + d).
Gene expression of MBD-4 in liver samples of multiple
trauma mice
Increase of MBD-4 in mice liver after multiple trauma
was verified by real-time PCR. Analogue to plasma levels
expressions raised after 6 h (4.3-fold of sham ± 3.4) and
12 h (2.9-fold of sham ± 2.3) up to 5.0-fold of sham ex-
pression. The MDB-4 expression reached sham levels
after 24 h (1.0-fold of sham ± 0.5) (Fig. 4).
Induction of HBD-2 in immortalized hepatocytes
To evaluate induction of HBD-2 in immortalized hepa-
tocytes (Hep G2), cells were stimulated with IL-6
(8.6 ng/ml ± 0.1), Staphylococcus aureus (11.2 ng/ml ±
1.1) and Staphylococcus aureus in combination with IL-
6 (11.5 ng/ml ± 0.8). Lysates were tested by Elisa (Fig. 5).
HBD-2 induction increased compared to control
(5.2 ng/ml ± 1) but interestingly stimulation with SA and
IL-6 did not cause a higher HBD-2 expression compared
to stimulation with SA.
Role of TLR2 in HBD2 induction in Hep G2 cells
HBD-2 induction is regulated by toll-like receptors, es-
pecially TLR2. Hep G2 were incubated with TLR2 block-
ing antibody (αTLR2), SA and SA together with αTLR2
(Fig. 6). After neutralisation with αTLR2 HBD-2 concen-
tration was slightly decreased compared to control levels
(7.3 ng/ml ± 0.9). The increase of HDP after treatment
with SA + αTLR2 was significantly lower compared to
stimulation with SA alone. Significant HBD-2 up-
regulation could be shown after stimulation with SA
(10.0 ng/ml ± 1.3).
Discussion
Due to extended wounds and open fractures multiple in-
jured patients are exposed to a multiplicity of invading
gram-positive and -negative bacteria. Regarding this
precarious premises one might believe that the overall
sepsis rate is relatively low [2, 23]. In a previous study
we were able to demonstrate that plasma of multiple
injured patients provides an increased antimicrobial ac-
tivity compared to healthy individuals [5]. In addition we
detected HDP with its direct ability to invade microbes
as possible effectors for the antimicrobial capacity.






























Fig. 1 Concentration of host defence peptides in plasma of humans and mice after multiple trauma. a ELISA analysis shows HBD-2 in plasma
samples of multiple traumatized patients from day 0, day 3, day 7 and day 14 after multiple trauma. Expression was compared to the expression
of a healthy control group. b In trauma mouse model significant induction of MBD-4 was detected directly after hit. Analogue to human the

























Fig. 2 Analysis of different sources for HBD-2 in human plasma.
Samples of skin, liver and PMN of healthy donors were tested by
Elisa analysis. Human liver samples contain similar concentrations of
HBD- 2 compared to skin. Neutrophil granulocytes hold lowest levels
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Nevertheless a possible source for the HDP and possible
regulating pathways have not been investigated yet.
The liver is known as a major source of acute
phase proteins, which are recognized as important
components of the innate immune system [16, 24]. In
the current study we could show that liver tissue
contains similar amounts of HBD-2 as skin tissue,
which is recognized as a main producer for HBD
[25]. Therefore we analysed the HBD-2 expression in
liver tissue immunohistochemically and could detect
hepatocytes as the main producer. Due to the fact
that human hepatocytes of multiple injured patients is
hardly available for research, we had to apply an
established multiple trauma mouse model [26]. MBD-
4 constitutes an inducible orthologues of HBD-2 and
holds strong antimicrobial activity as well [27].
In the present study we were able to show, that the
time course of MBD-4 levels in plasma of trauma mice
has a similar trend to the HBD-2 levels in plasma of
multiple injured patients. Highest levels of MBD-4 were
human
mouse
MBD-4in liver tissue of
multiple trauma mouse





Fig. 3 Host defence peptides in liver tissue of human donor and multiple traumatised mice. a and b Immunohistochemistry reveals expression of
HBD-2 in healthy human liver tissue. Negative control studies were carried out by absorption of the primary antibody by recombinant protein
(1:500 dilution). c and d MBD-4 was stained in liver tissue samples of day 1 after multiple trauma. Compared to control, posttraumatic liver
samples of mice show high immunoreactivity for MBD-4



























Fig. 4 Elevation of MBD-4 in liver cells of mice after multiple trauma.
Induction of MBD-4 in liver of traumatised mice over a period of 3 days
detected by real-time PCR. Significant elevation of MBD-4 can be de-
tected after 6 h after trauma compared to control group. * = p <0.05




















Fig. 5 In vitro stimulations of HBD-2 in Hep G2 cells. Human immor-
talized liver cell (Hep G2) were stimulated with bacteria and proin-
flammatory cytokines and concentrations of HBD-2 in lysates were
analysed by ELISA. Significant up-regulation of HBD-2 after stimula-
tion with SA and SA + IL-6 were detected in HepG2 cells. * = p < 0.05
versus control
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detected immediately after trauma, decreased afterwards
and even after 7 days plasma concentrations did not
reach the concentration of the heathy mice.
In further investigations we demonstrated that MBD-4
expression is induced in liver tissue after multiple
trauma. The plasma concentrations of MBD-4 correlated
with their expression in liver. These findings were sup-
ported by our immunohistochemical staining of liver tis-
sue from traumatised mice, in which we determined
higher MBD-4 concentrations compared to liver of a
healthy mice. It can be assumed that liver is one source
for HDP in plasma after multiple injury.
Hypovolemic shock, hepatic ischemia and reperfusion
injury as it occurs in multiple trauma patients stimulate
the production of reactive oxygen species and the release
of cytokines [28]. To get one step forward to compre-
hend the regulation of HBD-2 after multiple trauma we
stimulated liver tissue with cytokines and gram-positive
bacteria. As shown before bacteria seem to be a strong
inducer for lysozyme in different tissues [29]. With
regards to open fracture, wounds and deep tissue contu-
sion, bacteria are a major cause for systemic infection
after trauma. Our in vitro data revealed that SA induce
HBD-2 in liver. Tissue damage seems to be another initi-
ator of posttraumatic inflammatory reaction and besides
the degree of tissue damage correlates with release of
pro-inflammatory cytokines like IL-6 [30–32]. Due to
the fact that IL- 6 plays a major role in posttraumatic
inflammatory reaction [33], we tested the key player
for its effect on HBD-2 expression in liver tissue. IL-6
shows non-significant induction of HBD-2 in liver tis-
sue and hepatocytes, whereas SA seems to be the
strongest inductor. HBD-2 induction by gram-positive
bacteria has been reported in epithelial cells but not
in hepatocytes [34, 35].
Relating to systemic inflammation and shock syn-
drome, liver constitutes a key figure in terms of the
regulation of mediators (28) and regulate innate defence
after severe injury (29).
To extend the comprehension of HBD-2 regulation in
hepatocytes we identified one signalling pathway in
hepatocytes. As shown before in epithelial cells TLR2 is
involved in the regulation of HBD-2 [36, 37]. Further-
more TLR constitute the major mediators of inflamma-
tory responses in liver and recognize microbial
components as well as endogenous ligands from dam-
aged or stressed cells [38, 39].
Toll-like receptors promote proinflammatory signal-
ling such as the nuclear factor-κB, c-Jun-N-terminal kin-
ase (JNK), p38, and interferon pathways in the liver and
regulate antiviral and antibacterial responses, hepatic in-
jury, and wound healing [39]. In the present study we
could demonstrate, that after blocking TLR2 with neu-
tralizing antibodies, stimulation of hepatocytes with SA
showed no effect. We assume that TLR 2 is not only in-
volved in HBD-2 regulation in epithelial cells, but also in
hepatocytes.
Conclusion
For the first time we provide evidence, that the liver is
involved in the regulation of HBD-2 after multiple
trauma. With the current study we increase the under-
standing of the complex immune reaction after severe
injury. We are well aware of the fact that there are other
sources for HBD-2 which can be recruited in case of
trauma. Furthermore it can be assumed that there exists
a multiplicity of other HDP and other features of this
heterogenic group with respect to multiple trauma and
critical care. Considering the complexity of this issue,
the role of HDP in trauma will require further attention.




















Fig. 6 Role of TLR2 in HBD-2 induction in Hep G2 cells. TLR2 was blocked with Antibodies (αTLR2) and stimulated with SA afterwards. The induc-
tion of HBD-2 in immortalized liver cell culture was measured by Elisa after stimulation. Compared to sample with blocked TLR2 a significant in-
crease can be seen for HBD-2 after stimulation with SA. * = p < 0.05 SA versus SA + αTLR2
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